Disclaimer: This article is for informational purposes only. It should not be considered a Medical Advice. Not all information will be accurate. Consult a health professional before making any significant health decisions.
As per a recent study, a drug has been developed that has been recorded to help lose weight among obese and overweight people at a much faster rate. As per Science Alert, this drug, Tirzepatide, is equivalent to the surgical options and has delivered incredible results among the participants of the trial. Participants lost as much as 16% of their body weight or more in 72 weeks.
The American company Eli Lilly and Company has developed the drug, and it is given in the form of an injection just once a week. Tirzepatide mimics the naturally found hormone activity, the incretins, which help lose weight. This natural hormone regulates metabolism by decreasing sugar levels in the blood post-meal.
The drug Tirzepatide comprises two specific forms of the hormone incretin: the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Though GLP-1 was previously approved as a drug for weight loss in 2021, the new weight loss formula appears to be more promising for losing weight quickly.
Phase three of this ongoing study has shown promising results from the seventy-two-week clinical trials that involved more than 2500 participants who were morbidly obese. The participants were also asked to reduce their calorie intake and increase physical activities. The drug was injected either in the quantities of 5, 10, or 15 mg once a week. Regardless of the amount of drug administered, the participants in the study have reported observing great results.
Despite the promising results, Tirzepatide may not suit everybody who takes it. A few people reported adverse effects post consumption of the medicine. Side effects like nausea, vomiting, and constipation were the most common effects reported after consuming the drug.